Literature DB >> 33452978

Effects of Zoniporide and BMA-1321 Compound on the Rate of Oxygen Absorption by Cardiomyocyte Mitochondria in Rats with Experimental Chronic Heart Failure.

A A Spasov1,2, N A Gurova3, T A Popova1, V N Perfilova1, V V Vishnevskaya1, M V Kustova1, N V Ovsyankina1, A A Ozerov1,2.   

Abstract

Uncoupling of respiration and ATP production by myocardial mitochondria was observed in rats with chronic isoproterenol intoxication (L-isoproterenol subcutaneously, 1 mg/kg, for 10 days) in comparison with controls (injected with the solvent). Inhibitors of NHE-1 zoniporide (1 mg/kg intraperitoneally, 13 days) and BMA-1321 compound (0.92 mg/kg intraperitoneally, 13 days) improved the mitochondrial function in rats with isoproterenol-induced cardiac failure: respiratory control coefficients increased, more so for the respiratory chain complex II, the main source of ROS in heart failure. The effect of BMA-1321 was more manifest (53%; p<0.05) in comparison with zoniporide (35%; p<0.05).

Entities:  

Keywords:  (NHE-1) inhibitors; Na-H exchange; experimental chronic heart failure; mitochondrial dysfunction

Year:  2021        PMID: 33452978     DOI: 10.1007/s10517-021-05059-w

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

1.  NEUROPROTECTIVE PROPERTIES OF A NEW INHIBITOR OF NA+/H+ EXCHANGER (COMPOUND RU-1355) ON THE MODEL OF FOCAL ISCHEMIA IN RATS.

Authors:  A A Spasov; V U Murav'eva; N A Gurova; N I Cheplyaeva; E V Reznikov; V A Anisimova
Journal:  Eksp Klin Farmakol       Date:  2016-08

2.  [Cardioprotective properties of zoniporide studied on experimental ischemia and reperfusion models in rat myocardium].

Authors:  N A Gurova; A A Spasov; A S Timofeeva; A A Zheltova; V Iu Fedorchuk
Journal:  Eksp Klin Farmakol       Date:  2013

3.  Mitochondrial reactive oxygen species (ROS) as signaling molecules of intracellular pathways triggered by the cardiac renin-angiotensin II-aldosterone system (RAAS).

Authors:  V C De Giusti; C I Caldiz; I L Ennis; N G Pérez; H E Cingolani; E A Aiello
Journal:  Front Physiol       Date:  2013-05-30       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.